Bandingkan Harga & Kinerja Pembangunan Jaya Ancol Tbk. (PJAA) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Pembangunan Jaya Ancol Tbk. dan Organon Pharma Indonesia Tbk.: Pembangunan Jaya Ancol Tbk. diperdagangkan di Rp470 (kapitalisasi pasar 748,8 M, volume 24 jam 195,5 rb), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Pembangunan Jaya Ancol Tbk. jauh lebih besar — sekitar 7,2× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| PJAA | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 748,8 M | 104,4 M |
Volume | 195,5 rb | — |
Lot | 1,96 rb | — |
Perputaran | 90,23 jt | — |
Harga Rata-rata | 461,54 | — |
Nilai Transaksi | 90,23 jt | — |
Harga Ekuilibrium Indikatif | 464 | — |
Volume Ekuilibrium Indikatif | 1 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Pembangunan Jaya Ancol Tbk.
PT Pembangunan Jaya Ancol (Company) was established base on notarial deed No. 33 of Achmad Abid SH, dated July 10, 1992. The Company’s articles of association has been amended several times, most recently by notarial deed No. 13 of Mrs. Aulia Taufani, S.H., dated April 01, 2004.
Selengkapnya di halaman PJAA →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
